Status:

COMPLETED

Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Obesity

Diabetes

Eligibility:

All Genders

18-70 years

Brief Summary

An original cohort of 43 patients were recruited for analysis of anthropometrics, metabolic profile, skeletal muscle biopsy, echocardiogram at baseline, 3 months and 9 months post bariatric surgery. W...

Eligibility Criteria

Inclusion

  • The subjects in this study will represent both male and female patients with clinically severe obesity (BMI \> 40kg/m2 or 35kg/m2 with significant obesity related co-morbidities), who have chosen to undergo elective bariatric surgery. Patients are screened through the University of Texas Houston Bariatric Surgery Center (UTHBSC) and are evaluated for bariatric surgery, defined in this study as small pouch gastric bypass with Roux-en-Y (SPGB), or laparoscopic adjustable gastric banding (LAGB). Adults (\>18)from diverse ethnic backgrounds, with clinically severe obesity, are eligible to be evaluated for bariatric weight loss surgery in the UTHBSC. Candidates considered for the study are patients who not only fulfill the criteria for weight loss surgery, but also demonstrate a high likelihood of complying with the long-term follow-up that is required for a successful study.
  • Patients who have components of the metabolic syndrome (hypertension, diabetes, and dyslipidemia) will be included if these complications do not preclude a safe operation. .

Exclusion

  • Exclusion criteria include age over 70 years, current history of smoking, coronary artery disease, congestive heart failure, ischemic cardiomyopathy, known peripheral vascular disease, severe psychiatric disease, any medical problem or physical contraindication for surgery (as determined by the physician) and pregnancy. This study will be limited to adults since the safety of gastric bypass surgery has not been shown to be safe in children in large clinical trials
  • \-

Key Trial Info

Start Date :

May 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2008

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT00178633

Start Date

May 1 2004

End Date

August 1 2008

Last Update

November 23 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas, Health Sciences Center Houston

Houston, Texas, United States, 77030